Fatty acid treatment
AssigneeScotia Holdings PLC
InventorsDavid F. Horrobin, Brenda E. Reynolds
Life of this patent
Estimating the term…
Abstract
Increasing gut calcium absorption in humans or animals by the administration of GLA, DGLA or LA as such or in salt or other pharmacologically acceptabe form, optionally in association with EPA, DHA or other EFA in similar forms, specifically useful in treatment of osteoporosis.
Claims8
A method for increasing gut calcium absorption in humans or animal comprising administering a calcium salt of gamma-linolenic acid (GLA), dihomo-gamma-linolenic add (DGLA) or linoleic acid (LA), optionally in association with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or other essential fatty acid of the n-3 or n-6 series, additional to the calcium salt of GLA, DGLA or LA, as such or pharmacologically acceptable form convertible thereto in the body.
A method for increasing the systemic calcium pool by stimulating both an increased absorption of and a reduction of urinary excretion of calcium in humans or animals comprising administering the calcium salt of GLA, DGLA or LA, optionally in association with EPA, DHA or other essential fatty acid of the n-3 or n-6 series, additional to the calcium salt of GLA, DGLA or LA, as such or pharmacologically acceptable form convertible thereto in the body.
Dependencies are inferred from the claim text.